| APC | antigen presenting cells |
| CIN | cervical intraepithelial neoplasia |
| CPS | combined positive score |
| CRISPR | clustered regularly interspaced palindromic repeats |
| CTLA-4 | cytotoxic T lymphocyte associated protein 4 |
| HPV | human papilloma virus |
| ICI | immune checkpoint inhibitors |
| IHC | immunohistochemistry |
| LAG-3 | lymphocyte-activation gene 3 |
| mDOR | median duration of response |
| MHC | major histocompatibility complex |
| NECC | neuroendocrine carcinoma of the cervix |
| NSCLC | non-small cell lung carcinoma |
| ORR | objective response rate |
| OS | overall survival |
| PD-1 | programmed death-1 |
| PDL1 | programmed death ligand-1 |
| SCC | squamous cell carcinoma |
| TALENs | Transcription Activator-Like Effector Nucleases |
| TIGIT | T cell immunoglobulin and ITIM domain |
| TILs | tumour infiltrating lymphocytes |
| TIM-3 | T cell immunoglobulin and mucin-domain–containing molecule 3 |
| TMB | tumour mutational burden |
| VEGF | vascular endothelial growth factor |